AB
GILD icon

Atlas Brown’s Gilead Sciences GILD Stock Holding History

Atlas Brown’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Sell
3,508
-5
-0.1% -$659 0.12% 161
2026
Q1 		$490K Buy
3,513
+5
+0.1% +$700 0.15% 136
2025
Q4 		$431K Buy
3,508
+3
+0.1% +$365 0.13% 147
2025
Q3 		$389K Buy
3,505
+5
+0.1% +$568 0.12% 155
2025
Q2 		$388K Hold
3,500
– – 0.12% 157
2025
Q1 		$392K Buy
3,500
+15
+0.4% +$1.55K 0.14% 145
2024
Q4 		$322K Buy
3,485
+30
+0.9% +$2.7K 0.11% 162
2024
Q3 		$290K Buy
3,455
+25
+0.7% +$1.91K 0.1% 172
2024
Q2 		$235K Buy
3,430
+10
+0.3% +$667 0.08% 185
2024
Q1 		$251K Buy
3,420
+10
+0.3% +$769 0.09% 177
2023
Q4 		$276K Hold
3,410
– – 0.11% 158
2023
Q3 		$256K Hold
3,410
– – 0.12% 153
2023
Q2 		$263K Hold
3,410
– – 0.12% 156
2023
Q1 		$283K Hold
3,410
– – 0.13% 143
2022
Q4 		$293K Sell
3,410
-7,276
-68% -$576K 0.14% 138
2022
Q3 		$659K Buy
10,686
+109
+1% +$6.87K 0.34% 92
2022
Q2 		$654K Buy
10,577
+47
+0.4% +$2.91K 0.31% 93
2022
Q1 		$626K Sell
10,530
-464
-4% -$29.7K 0.26% 114
2021
Q4 		$798K Buy
10,994
+692
+7% +$47.7K 0.31% 96
2021
Q3 		$720K Buy
10,302
+613
+6% +$43.1K 0.31% 100
2021
Q2 		$667K Buy
9,689
+2,963
+44% +$198K 0.29% 101
2021
Q1 		$435K Sell
6,726
-633
-9% -$40.8K 0.21% 121
2020
Q4 		$429K Buy
7,359
+580
+9% +$35K 0.22% 116
2020
Q3 		$428K Buy
6,779
+120
+2% +$8.32K 0.25% 101
2020
Q2 		$507K Buy
6,659
+184
+3% +$14.1K 0.32% 92
2020
Q1 		$484K Buy
6,475
+1,234
+24% +$85.3K 0.38% 79
2019
Q4 		$341K Buy
5,241
+1,969
+60% +$128K 0.21% 110
2019
Q3 		$207K Sell
3,272
-255
-7% -$16.7K 0.15% 143
2019
Q2 		$238K Buy
3,527
+128
+4% +$8.42K 0.16% 134
2019
Q1 		$221K Buy
3,399
+61
+2% +$4.05K 0.16% 138
2018
Q4 		$209K Sell
3,338
-3,928
-54% -$275K 0.16% 135
2018
Q3 		$561K Sell
7,266
-274
-4% -$20.7K 0.34% 86
2018
Q2 		$579K Sell
7,540
-459
-6% -$32.4K 0.14% 80
2018
Q1 		$603K Buy
7,999
+52
+0.7% +$4.13K 0.11% 76
2017
Q4 		$646K Buy
7,947
+52
+0.7% +$3.95K 0.12% 72
2017
Q3 		$640K Buy
7,895
+250
+3% +$19.1K 0.14% 66
2017
Q2 		$541K Sell
7,645
-376
-5% -$25K 0.47% 65
2017
Q1 		$545K Sell
8,021
-150
-2% -$10.5K 0.43% 66
2016
Q4 		$646K Hold
8,171
– – 0.27% 56
2016
Q3 		$646K Buy
8,171
+204
+3% +$16.6K 0.27% 56
2016
Q2 		$665K Buy
7,967
+2,560
+47% +$227K 0.27% 52
2016
Q1 		$497K Buy
5,407
+320
+6% +$28.9K 0.21% 64
2015
Q4 		$455K Buy
5,087
+450
+10% +$46.8K 0.29% 58
2015
Q3 		$455K Buy
4,637
+103
+2% +$11.4K 0.2% 60
2015
Q2 		$529K Buy
4,534
+697
+18% +$76.2K 0.21% 58
2015
Q1 		$377K Buy
+3,837
New +$390K 0.1% 78

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Atlas Brown's GILD Position: Q2 2026 in Review

Atlas Brown reduced its Gilead Sciences (GILD) stake by 0.14% in Q2 2026, selling an estimated $659 and leaving 3,508 shares worth $443K. The position accounts for 0.12% of the portfolio, ranked #161.

Atlas Brown first reported a position in GILD in Q1 2015 and has held it in 46 quarters since. The position peaked at $798K in Q4 2021. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Atlas Brown held 3,508 shares of Gilead Sciences worth $443K as of Q2 2026.
  • Atlas Brown sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
  • Gilead Sciences made up 0.12% of Atlas Brown's portfolio in Q2 2026, its #161 holding.
  • Atlas Brown first reported a position in Gilead Sciences in Q1 2015 and has held it in 46 quarters since.
  • Atlas Brown's Gilead Sciences position peaked at $798K in Q4 2021.
  • 425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.